Search Results

Spaulding Rehabilitation Hospital, a teaching affiliate of Harvard Medical School, and Highland Instruments, Inc., jointly announced the advancement into Phase II of their National Institutes of Health funded Clinical Trial investigating Highland Instruments’ Electrosonic Stimulation, a novel noninvasive brain stimulation technology, to treat Carpal Tunnel Syndrome1.

bioAffinity Technologies today announced that Sandeep Bansal, M.D., Medical Director of Lung Innovations Network, has joined the Company’s Medical and Scientific Advisory Board.

Highland Therapeutics Inc. today announced the appointment of Stephanie C. Read as President/Chief Executive Officer, the appointment of Scott Myers as Chair of the Board and the additions of Kevin Bain and Ildiko Mehes as independent members of the Board of Directors.

We are in an unprecedented time in neurotherapeutics. Medicines that address the causative disease biology underlying central nervous system

Highland Therapeutics Inc. (“Highland”) today announced the appointment of Stephanie C. Read to its Board of Directors, effective November 13, 2020. Ms. Read brings to the Company a wealth of experience and expertise gained from over twenty years of tenure in the pharmaceuticals industry, including in the ADHD market. “It is my pleasure to welcome Ms. Read, an accomplished executive, to the Highland Board of Directors,” said

Following disappointing results for an antibiotic candidate whose development program is now being suspended, Spero Therapeutics is looking to extend its cash runway while it focuses on other assets in its pipeline.

Highland Therapeutics Inc. (“Highland”) today announced two executive appointments at its wholly owned subsidiaries. Mr. Danny Villeneuve has assumed the role of Executive Vice President and Chief Commercial Officer and Dr. Bev Incledon has been promoted to the role of Executive Vice President and Chief

Following two layoffs in less than three months, Viracta Therapeutics may have around 18 employees left to advance its efforts to bring lead product candidate nana-val to market.